Cite
HARVARD Citation
Smith, P. et al. (2021). Dosing will be a key success factor in repurposing antivirals for COVID‐19. British journal of clinical pharmacology. 87 (9), pp. 3451-3454. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smith, P. et al. (2021). Dosing will be a key success factor in repurposing antivirals for COVID‐19. British journal of clinical pharmacology. 87 (9), pp. 3451-3454. [Online].